A comparative clinical study to evaluate the effect of kayaseka followed by daily purgation and immediate purgation in Rheumatoid arthritis

A comparative clinical study to evaluate the effect of kayaseka followed by nitya virechana and sadyo virechana in amavata (Rheumatoid arthritis) - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057283

Enrollment

Registered

2023-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects aged between 18-60 years of both genders. 2.Subjects fulfilling the diagnostic criteria of Amavata. 3.Subjects indicated for Kayaseka and Virechana.

Exclusion criteria

Exclusion criteria: 1.Subjects associated with uncontrolled Diabetes Mellitus, Hypertension, Cardiac diseases and other systemic disorders. 2.Rheumatoid arthritis patients with gross deformity. 3.Pregnant and lactating women. • Patient with skin lesions, cuts, wounds

Design outcomes

Primary

Measure	Time frame
Reduction in sandhi shotha,sandhi shoola,sandhi stabdathaTimepoint: • Before starting treatment – on 0th day • After completion of the treatment – on 8th day • Follow up period - 24th day.	—

Secondary

Measure	Time frame
Reduction in CRP titer,RA factor titer & EULAR ScoreTimepoint: • Before starting treatment – on 0th day • After completion of the treatment – on 8th day • Follow up period - 24th day.	—

Countries

India

Contacts

Public ContactDr Shaila Bhorannavar

Government ayurveda medical College Bangalore 09

shailaborannavar@gmail.com8296634203

Outcome results